COMPARING ORAL PARACETAMOL DOSES IN PAEDIATRICS WITH THE NEW BNF-C DOSING

Nour Ajjan1, Sian Shenton1

  • 1Leeds Teaching Hospitals Trust.

Insights

Pediatric paracetamol dosing in the UK has changed, with the BNF-C recommending a lower maximum daily dose. This audit found many prescribers unaware of the updated guidelines, leading to potential overdosing despite local guidelines. Educational interventions are needed.

Area of Science:

  • Pediatric pharmacology
  • Clinical pharmacy practice
  • Pain management

Background:

  • The British National Formulary for Children (BNF-C) updated paracetamol dosing in 2014-2015, reducing the maximum daily oral dose from 90 mg/kg/day to 75 mg/kg/day for post-operative pain.
  • Local guidelines, such as the Trust Paediatric Acute Pain Management Manual, advised a maximum daily dose of 80 mg/kg/day, creating a discrepancy with national recommendations.

Purpose of the Study:

  • To audit the implementation of updated national paracetamol dosing guidelines in pediatric patients.
  • To compare current pediatric oral paracetamol prescribing practices against the BNF-C and local Trust guidelines.

Main Methods:

  • Data collected over two weeks in September 2014 from pediatric medical and surgical wards.
  • Inclusion criteria: patients aged 1 month to 18 years prescribed oral paracetamol for pain or pyrexia.
  • Data collected included patient weight, age, and reason for admission to assess prescribing accuracy and adherence to guidelines.

Main Results:

  • 19/24 medical patients received age-banded dosing per BNF-C; 5/24 were dosed by weight. No patients exceeded 80 mg/kg/day.
  • 87% of surgical patients were dosed by weight, with 69% within the 75 mg/kg/day maximum. 31% exceeded 75 mg/kg/day but remained below 80 mg/kg/day.
  • The Trust Manual recommended 20 mg/kg 6-hourly (max 80 mg/kg/day), differing from BNF-C's age-banded approach.

Conclusions:

  • Medical wards generally followed BNF-C age-banded dosing, while surgical wards leaned towards weight-based dosing per the Trust Manual.
  • A significant number of patients received doses exceeding the BNF-C's 75 mg/kg/day maximum, indicating a lack of prescriber awareness of the updated national guidelines.
  • An educational poster was distributed to raise awareness about the maximum daily paracetamol dose of 75 mg/kg/day.
Abstract

Keywords:
AbstractOral

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
682
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
636
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
351
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
312
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
419
Dosage Regimen Designs: Nomograms and Tabulations01:23

Dosage Regimen Designs: Nomograms and Tabulations

Nomograms and tabulations are vital tools used by clinicians to design accurate and individualized dosage regimens. These instruments provide a straightforward method for adjusting dosages based on individual patient characteristics, including age, weight, and physiological condition. The foundation of a drug's nomogram is population pharmacokinetic data collected and analyzed using specific models. This data simplifies complex equations, presenting them diagrammatically or tabularly for easy...
276